Skip to main content

Table 1 Pulmonary function testing results before and after intrathecal baclofen treatment

From: Complex regional pain syndrome with associated chest wall dystonia: a case report

  FVC FEV1 FEF 25-75% PEF TLC RV DLCO
Study 1
Pre-Bronchodilator
1.83 L (44% Ref) 1.60 L (49% Ref) 2.20 L/sec (73% Ref) 5.34 L/sec (71% Ref) 2.71 L (45% Ref) 0.88 L (40% Ref) 12.20 mL/mmHg/min (44% Ref)
Post -Bronchodilator 2.06 L (50% Ref) 1.78 L (54% Ref) 2.44 L/sec (81% Ref) 4.62 L/sec (62% Ref) NA NA NA
Study 2††
Pre-Bronchodialtor
1.95 L (47% Ref) 1.57 L (49% Ref) 1.59 L/sec (53% Ref) 4.74 L/sec (64% Ref) 3.07 L (52% Ref) 1.10 L (50% Ref) 11.00 mL/mmHg/min (36% Ref)
Post -Bronchodilator 2.18 L (53% Ref) 1.79 L (55% Ref) 1.97 L/sec (66% Ref) 4.89 L/sec (66% Ref) NA NA NA
  1. † Patient intrathecal medication dose at time of study: Baclofen 0 μg/day, Dilaudid 26.5 mg/day
  2. †† Patient intrathecal medication dose at time of study: Baclofen 400 μg/day, Dilaudid 21.5 mg/day